spacer
  Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institute & Offices | Training & Employment | Contact Us
spacer
spacer CDC Centers for Disease Control and Prevention Home Page spacer
CDC en Español
spacer
 
spacer
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
spacer
spacer
spacer
spacer
  DLS Content
space
arrow DLS Home
space
arrow Best Practices
space
arrow CLIA
space
arrow Genetics
space
arrow Institutes
space
arrow International
space
arrow MASTER
space
arrow Monitoring
space
arrow MPEP
space
arrow NLTN
space
arrow Publications
space
arrow Quality Conferences
space
arrow Training
space
arrow Waiver
space

  Other DLS Resources
space
arrow Resource Links
space
spacer spacer
spacer
spacer
spacer
Waived Tests
spacer
spacer

Purpose

In 2005, CDC, Division of Laboratory Systems, published the MMWR Recommendations and Reports on "Good Laboratory Practices for Waived Testing Sites." The recommendations in this report are intended to be a resource for physicians, nurses and others who perform waived tests in sites holding a Clinical Laboratory Improvement Amendments of 1988 (CLIA) Certificate of Waiver. The recommendations were published to promote quality testing, reduce testing errors, and enhance patient safety.

To increase awareness, and to encourage the use of good laboratory practices, DLS is developing tools based on the recommendations that waived sites can use for quick reference. One tool is a poster (below), listing 10 basic recommendations for good laboratory practices. Another tool, under development, is a brochure that explains the recommendations in a simple-to-understand format.

Background

All facilities in the United States that perform laboratory testing on human specimens for health assessment or the diagnosis, prevention, or treatment of disease are regulated under CLIA (1). Waived tests include test systems cleared by FDA for home use and those tests approved for waiver under the CLIA criteria. Although CLIA requires that waived tests must be simple and have a low risk for erroneous results, this does not mean that waived tests are completely error-proof. Errors can occur anywhere in the testing process, particularly when the manufacturer's instructions are not followed and when testing personnel are not familiar with all aspects of the test system.

Some waived tests have potential for serious health impacts if performed incorrectly. For example, results from waived tests can be used to adjust medication dosages, such as prothrombin time testing in patients undergoing anticoagulant therapy and glucose monitoring in diabetics. In addition, erroneous results from diagnostic tests, such as those for human immunodeficiency virus (HIV) antibody, can have unintended consequences. To decrease the risk of erroneous results, the test needs to be performed correctly, by trained personnel and in an environment where good laboratory practices are followed.

Tools for Using Waived Tests

References

(1) Clinical Laboratory Improvement Amendments of 1988, 42 U.S.C. 263a PL100-578 (1988).


This page last reviewed: 7/23/2009
spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
spacer FirstGovDHHS Department of Health
and Human Services